March 2016

Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The company’s findings are outlined in the recently published research article, “A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti-HIV Antibodies and Viral RNA” in the Journal of… Read More »
Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type.
Learn More